期刊文献+

核因子E2相关因子2与肾间质纤维化研究进展 被引量:2

原文传递
导出
摘要 肾间质纤维化(renal interstitial fibrosis,RIF)是慢性肾衰竭的主要原因之一,是各种慢性肾脏疾病的共同结果,其发病机制与肾间质成纤维细胞,肾小管上细胞,炎性细胞以及肾小管周围毛细血管内皮细胞的转型,损伤和数量相关。氧化应激是导致细胞损伤、衰老和死亡的主要原因之一,其在神经退行性疾病、缺血性心脏病、肝、肺纤维化和癫痫等重要疾病的发生和发展中起重要作用。
出处 《中华生物医学工程杂志》 CAS 2014年第6期480-483,共4页 Chinese Journal of Biomedical Engineering
基金 河北省医学科研重点课题计划(ZD20140125)
  • 相关文献

参考文献38

  • 1曹玉英.肾间质纤维化的研究进展[J].现代医药卫生,2011,27(23):3592-3594. 被引量:5
  • 2卢明珍,张璐娟.阿魏酸钠对肺源性心脏病患者内皮细胞及氧化应激的影响[J].长冶医学院学报,2012,26(1):22-25.
  • 3Chitra L, Boopathy R. Altered mitochondrial biogenesis and its fusion gene expression is involved in the high-altitude adaptation of rat lung[J ]. Respir Physiol Neurobiol, 2014, 192: 74-84.
  • 4皮明山,吴钰祥,茹琴,李超英.常见毒品对大脑神经元损伤的研究进展[J].神经损伤与功能重建,2014,9(1):63-67. 被引量:10
  • 5Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap 1- Nrf2-ARE pathway [J]. Annu Rev Pharmacol Toxicol, 2007, 47 : 89-116.
  • 6Eddy AA. Molecular insights into renal interstitial fibrosis [J].J Am Soe Nephrol, 1996, 7: 2495-2508.
  • 7楚非,邹万忠,孙锁柱,韩志惠,王盛兰.大鼠肾小管间质纤维化中肾小管上皮细胞表型转化的研究[J].中华肾脏病杂志,2003,19(1):10-14. 被引量:31
  • 8龚蓉,冯梅,付平.苦参碱抗肾间质纤维化的研究现状[J].四川医学,2007,28(4):358-360. 被引量:5
  • 9Yamaguchi 1, Tchao BN, Burger ML, et al. Vascular endothelial cadherin modulates renal interstitial fibrosis [J]. Nephron Exp Nephrol, 2012, 120: e20-e31.
  • 10Sun D, Wang Y, Liu C, et al. Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction [J]. Life Sci, 2012, 90: 900-909.

二级参考文献177

共引文献89

同被引文献44

  • 1SouabniH, ThomaV, BizouarnT, et al. Arachidonic acid isomers inhibit NADPH-oxidase activity by direct interaction with enzyme components[J]. Biochim Biophys Acta, 2012, 1818(9):2314-2324.
  • 2Cifuentes - PaganoE, CsanyiG, PaganoPJ. NADPH oxidase inhibitors:a decase of discovery from Nox2ds to HTS[J]. Cell Mol Life Sci, 2012, 69(14):2315-2325.
  • 3GorinY, BlockK. Nox4 and diabetic nephropathy:with a friend like this, who needs enemies?[J]. Free Radic Biol Med, 2013, 61:130-142.
  • 4GorinY, BlockK. Nox as a target for diabetic complications[J]. Clin Sci (Lond), 2013, 125(8):361-382.
  • 5Thallas-BonkeV, JhaJC, GraySP, et al. Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy[J]. Physiol Rep, 2014, 2(11).pii:e12192.
  • 6HoltermanCE, ThibodeauJF, KennedyCR. NADPH oxidase 5 and renal diseae[J]. Curr Opin Nephrol Hypertens, 2015, 24(1), 81-87.
  • 7EidAA, FordBM, BhandaryB, et al. Mammalian target of rapamycin regulates Nox4 - mediated podocyte depletion in diabetic renal injury[J]. Diabetes, 2013, 62(8):2935-2947.
  • 8LiuGC, FangF, ZhouJ, et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse[J]. Diabetologia, 2012, 55(9):2522-2532.
  • 9KinugasaS, TojoA, SakaiT, et al. Selective albuminuria via podocyte albumin transport in puromycin nophrotic rats is attenuated by an inhibitor of NADPH oxidase[J]. Kidney Int, 2011, 80(12):1328-1338.
  • 10BoyerF, VidotJB, DubourgAG, et al. Oxidative stress and adipocyte biology:focus on the role of AGEs[J]. Oxid Med Cell Longev, 2015, 2015:534873.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部